NeoGenomics (NEO) Acquires Oncology Division from Human Longevity for $37 Million
Go back to NeoGenomics (NEO) Acquires Oncology Division from Human Longevity for $37 MillionNEOGENOMICS (NASDAQ: NEO) | Delayed: 14.16 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $14.16 | 52 Week High | $9.54 | |||
Open | $14.16 | 52 Week Low | $5.49 | |||
Day High | $14.16 | P/E | 354.00 | |||
Day Low | $14.16 | EPS | $0.04 | |||
Volume | 6,804 |